BRCA1 and ovarian cancer: One study examined the development of chemoresistance in ovarian cancer cell lines and found that cell lines with functional BRCA1 developed paclitaxel resistance more quickly than cell lines with non-functional BRCA1 (due to gene silencing by hypermethylation) [26].